Novel 5,7-disubstituted (1,3)thiazolo(4,5-d)pyrimidin-2(3H)-one derivatives
Details for Australian Patent Application No. 2006231835 (hide)
International Classifications
Event Publications
18 October 2007 PCT application entered the National Phase
PCT publication WO2006/107257 Priority application(s): WO2006/107257
30 September 2010 Application Accepted
Published as AU-B-2006231835
14 October 2010 Corrigenda
Applications Accepted - Name Index Under the name AstraZeneca AB, Application No. 2006231835, under INID (54) correct the title to read Novel 5,7-disubstituted [1,3]thiazolo[4,5-d]pyrimidin-2(3H)-one derivatives
27 January 2011 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2006231836-Novel 5-substituted 7-amino-[1,3]thiazolo[4,5-d]pyrimidine derivatives
2006231819-Power assist control method, power assist controller and reposition device
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional

- Editable Word format reports
- For IP Professionals
- Multiuser